Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhTPO timing in chemotherapy-induced thrombocytopenia for lymphoma and lung cancer
ChiCTR-OPC-15006803Phase 4Recruiting
- Sponsor
- Affiliated Cancer Hospital of Nanjing Medical University
- Start
- Jul 2014
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of recombinant human thrombopoietin in chemotherapy-induced thrombocytopenia (CIT), sponsored by Affiliated Cancer Hospital of Nanjing Medical University. Primary endpoint: blood routine examination. Started Jul 2014; status: recruiting.
02
Drugs
recombinant human thrombopoietin
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on ChiCTR-OPC-15006803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-15006803.